These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 37347432)
1. Effects of the COVID-19 Pandemic on SMA Screening and Care: Physician and Community Insights. Curry M; Peterson I; Belter L; Sarr F; Whitmire S; Schroth M; Jarecki J Neurol Ther; 2023 Oct; 12(5):1631-1647. PubMed ID: 37347432 [TBL] [Abstract][Full Text] [Related]
2. Assessment of Barriers to Referral and Appointment Wait Times for the Evaluation of Spinal Muscular Atrophy (SMA): Findings from a Web-Based Physician Survey. Curry MA; Cruz RE; Belter LT; Schroth MK; Jarecki J Neurol Ther; 2024 Jun; 13(3):583-598. PubMed ID: 38430355 [TBL] [Abstract][Full Text] [Related]
3. Awareness screening and referral patterns among pediatricians in the United States related to early clinical features of spinal muscular atrophy (SMA). Curry M; Cruz R; Belter L; Schroth M; Lenz M; Jarecki J BMC Pediatr; 2021 May; 21(1):236. PubMed ID: 34001052 [TBL] [Abstract][Full Text] [Related]
4. The Japan Registry for Adult Subjects of Spinal Muscular Atrophy (jREACT-SMA): Protocol for a Longitudinal Observational Study. Sahashi K; Hashizume A; Kuwatsuka Y; Chinen M; Saotome-Nakamura A; Ando M; Katsuno M JMIR Res Protoc; 2022 Dec; 11(12):e38878. PubMed ID: 36520510 [TBL] [Abstract][Full Text] [Related]
5. Pan-Canadian survey on the impact of the COVID-19 pandemic on cervical cancer screening and management: cross-sectional survey of healthcare professionals. El-Zein M; Ali R; Farah E; Botting-Provost S; Franco EL; Elife; 2023 Jun; 12():. PubMed ID: 37377399 [TBL] [Abstract][Full Text] [Related]
6. Spinal Muscular Atrophy Update in Best Practices: Recommendations for Diagnosis Considerations. Schroth M; Deans J; Arya K; Castro D; De Vivo DC; Gibbons MA; Ionita C; Kuntz NL; Lakhotia A; Neil Knierbein E; Scoto M; Sejersen T; Servais L; Tian C; Waldrop MA; Vázquez-Costa JF Neurol Clin Pract; 2024 Aug; 14(4):e200310. PubMed ID: 38915908 [TBL] [Abstract][Full Text] [Related]
7. Room to improve: The diagnostic journey of Spinal Muscular Atrophy. Carter M; Tobin A; Coy L; McDonald D; Hennessy M; O'Rourke D Eur J Paediatr Neurol; 2023 Jan; 42():42-46. PubMed ID: 36525883 [TBL] [Abstract][Full Text] [Related]
8. Telemedicine Use, Comfort, and Perceived Effectiveness in the Spinal Muscular Atrophy Community. Peterson IS; Belter LT; Curry MA; Jarecki J Telemed J E Health; 2024 Feb; 30(2):536-544. PubMed ID: 37566530 [No Abstract] [Full Text] [Related]
10. The Cure SMA Clinical Trial Experience Survey: A Study of Trial Participant Perspectives on Clinical Trial Management and Patient-Centric Management Practices. Peterson IS; Mazzella AJ; Belter LT; Curry MA; Cruz RE; Jarecki J Neurol Ther; 2022 Sep; 11(3):1167-1181. PubMed ID: 35635603 [TBL] [Abstract][Full Text] [Related]
11. Epidemiology, healthcare resource utilization and healthcare costs for spinal muscular atrophy in Alberta, Canada. Chen G; Sharif B; Gerber B; Farris MS; Cowling T; Cabalteja C; Wu JW; Maturi B; Klein-Panneton K; Jean K Mah J Med Econ; 2021 Nov; 24(sup1):51-59. PubMed ID: 34906030 [TBL] [Abstract][Full Text] [Related]
12. Drug treatment for spinal muscular atrophy type I. Wadman RI; van der Pol WL; Bosboom WM; Asselman FL; van den Berg LH; Iannaccone ST; Vrancken AF Cochrane Database Syst Rev; 2019 Dec; 12(12):CD006281. PubMed ID: 31825542 [TBL] [Abstract][Full Text] [Related]
13. The SMA Clinical Trial Readiness Program: creation and evaluation of a program to enhance SMA trial readiness in the United States. Peterson I; Cruz R; Sarr F; Stanley AM; Jarecki J Orphanet J Rare Dis; 2020 May; 15(1):118. PubMed ID: 32443972 [TBL] [Abstract][Full Text] [Related]
14. The Cure SMA Membership Surveys: Highlights of Key Demographic and Clinical Characteristics of Individuals with Spinal Muscular Atrophy. Belter L; Jarecki J; Reyna SP; Cruz R; Jones CC; Schroth M; O'Toole CM; O'Brien S; Hall SA; Johnson NB; Paradis AD J Neuromuscul Dis; 2021; 8(1):109-123. PubMed ID: 33104036 [TBL] [Abstract][Full Text] [Related]
15. A Digital Health Initiative (COVIDsmart) for Remote Data Collection and Study of COVID-19's Impact on the State of Virginia: Prospective Cohort Study. Schilling J; Klein D; Bartholmae MM; Shokouhi S; Toepp AJ; Roess AA; Sill JM; Karpov MV; Maney K; Brown KP; Levy BL; Renshaw KD; Dodani S; Jain P JMIR Form Res; 2023 Mar; 7():e37550. PubMed ID: 36795656 [TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
17. Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy. Dachs E; Piedrafita L; Hereu M; Esquerda JE; Calderó J Neuroscience; 2013 Oct; 250():417-33. PubMed ID: 23876328 [TBL] [Abstract][Full Text] [Related]
18. A mixed method study on the impact of living with spinal muscular atrophy in Malaysia from patients' and caregivers' perspectives. Ch'ng GS; Koh K; Ahmad-Annuar A; Taib F; Koh CL; Lim ESC Orphanet J Rare Dis; 2022 May; 17(1):200. PubMed ID: 35578241 [TBL] [Abstract][Full Text] [Related]